...4年下半年,COX-2抑制剂罗非昔布(万络,默克)因心血管不良反应问题全面退出市场,辉瑞公司的塞来昔布(西乐葆)和伐地昔布(Bextra)相继被发现存在类似情况,诺华公司的同类药物lumiracoxib(Prexige)也推迟了其在美国的上市日期,这一系列事件无疑给整个COX-2抑制...
基于298个网页-相关网页
Ironically, after filing the Bextra suit, "I was the disgruntled former employee," he said.
Kopchinski说,具有讽刺意义的是,当提交Bextra的诉讼后,我也成了一名心怀不满的前雇员。
The jump wasn't driven by a few high-profile drug problems, such as Merck's withdrawal of painkiller Vioxx in 2004 and Pfizer's suspension of rival painkiller Bextra in 2005.
暴涨不能归因于少数世人瞩目的药物问题,如2004年的默克公司止痛药万络退市和辉瑞公司类似的止痛药Bextra暂停上市。
One of those drugs was the anti-inflammatory medication Bextra, which Pfizer pulled off the market in 2005 after it was linked to increasing the risk of heart attacks and strokes.
其中一种药物是抗炎药伐地考昔(Bextra),在发现它可以增加心脏病和中风的危险性之后,辉瑞公司于2005年将其撤市。
Pfizer withdrew Bextra from the market in two thousand five because of links to heart attacks and other problems.
VOA: special.2009.09.11
A Pfizer division, Pharmacia & Upjohn, agreed to plead guilty to a criminal violation over the painkiller Bextra.
VOA: special.2009.09.11
Pfizer pushed sales of Bextra for several uses unapproved by the government because of safety concerns.
VOA: special.2009.09.11
应用推荐